1. Home
  2. BNTX vs ASX Comparison

BNTX vs ASX Comparison

Compare BNTX & ASX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BNTX
  • ASX
  • Stock Information
  • Founded
  • BNTX 2008
  • ASX 1984
  • Country
  • BNTX Germany
  • ASX Taiwan
  • Employees
  • BNTX N/A
  • ASX N/A
  • Industry
  • BNTX Biotechnology: Biological Products (No Diagnostic Substances)
  • ASX Semiconductors
  • Sector
  • BNTX Health Care
  • ASX Technology
  • Exchange
  • BNTX Nasdaq
  • ASX Nasdaq
  • Market Cap
  • BNTX 23.9B
  • ASX 22.5B
  • IPO Year
  • BNTX 2019
  • ASX 1995
  • Fundamental
  • Price
  • BNTX $114.00
  • ASX $10.44
  • Analyst Decision
  • BNTX Strong Buy
  • ASX Strong Buy
  • Analyst Count
  • BNTX 15
  • ASX 1
  • Target Price
  • BNTX $143.50
  • ASX N/A
  • AVG Volume (30 Days)
  • BNTX 659.5K
  • ASX 8.0M
  • Earning Date
  • BNTX 11-04-2024
  • ASX 01-30-2025
  • Dividend Yield
  • BNTX N/A
  • ASX 3.05%
  • EPS Growth
  • BNTX N/A
  • ASX N/A
  • EPS
  • BNTX N/A
  • ASX 0.23
  • Revenue
  • BNTX $3,390,698,192.00
  • ASX $18,693,593,707.00
  • Revenue This Year
  • BNTX N/A
  • ASX $6.13
  • Revenue Next Year
  • BNTX N/A
  • ASX $14.78
  • P/E Ratio
  • BNTX N/A
  • ASX $21.46
  • Revenue Growth
  • BNTX N/A
  • ASX N/A
  • 52 Week Low
  • BNTX $76.53
  • ASX $8.10
  • 52 Week High
  • BNTX $131.49
  • ASX $12.86
  • Technical
  • Relative Strength Index (RSI)
  • BNTX 48.71
  • ASX 59.25
  • Support Level
  • BNTX $109.52
  • ASX $9.81
  • Resistance Level
  • BNTX $115.34
  • ASX $10.55
  • Average True Range (ATR)
  • BNTX 4.24
  • ASX 0.24
  • MACD
  • BNTX -0.72
  • ASX 0.05
  • Stochastic Oscillator
  • BNTX 27.24
  • ASX 87.66

About BNTX BioNTech SE

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.

About ASX ASE Technology Holding Co. Ltd. (each representing Two)

ASE Technology Holding Co Ltd is a semiconductor assembly and testing firm. The company operates in segments: Packaging, Testing, and Electronic Manufacturing Services. Of these, Electronic Manufacturing Services contribute the maximum revenue. The packaging segment involves packaging bare semiconductors into completed semiconductors with improved electrical and thermal characteristics. The Testing Segment includes front-end engineering testing, wafer probing, and final testing services. In the EMS segment, the company designs manufactures, and sells electronic components and telecommunication equipment motherboards. The company is based in Taiwan but garners over half its sales from firms in the United States.

Share on Social Networks: